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A higher rate of patients suffering from inﬂammatory bowel diseases (IBD) are reported to experience
the symptom of fatigue compared with general population. Fatigue can impair quality of life of IBD
patients by limiting their daily functioning.
However, this problem is poorly understood and addressed. Our aim was to investigate the impact of
fatigue in IBD patients compared with controls, and to seek for relation between age and disease activity.
IBD patients aged between 16 and 75 years observed at our Unit from June 2011 through June 2012
were evaluated for fatigue. Patients were asked to ﬁll the fatigue impact scale (FIS) questionnaire. A
cohort of age- and sex-matched patients observed for other-than-IBD diseases were prospectively
enrolled to act as controls. Patients diagnosed with malignancies were excluded from evaluation.
Each group included 16 patients, of whom half aged over 65 years.
Fatigue was more severe in IBD patients than in controls (p ¼ 0.02), irrespective of age and disease
activity. IBD patients with moderate to severe disease activity showed worse fatigue compared with
controls at any age (p < 0.0001). Young IBD patients with low disease activity showed a trend toward
worse FIS score when compared with old IBD counterparts (p ¼ 0.06).
IBD signiﬁcantly impacted on fatigue in our series. Considering IBD patients in remission, younger
patients may experience worse fatigue. Further studies are needed to explore the effects of fatigue on
quality of life and the potential of appropriate intervention strategies.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Inﬂammatory bowel diseases (IBD), including Crohn's disease
(CD) and ulcerative colitis (UC), are chronic conditionsrgical, Neurologic, Metabolic
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by Elsevier Ltd. All rights reservedcharacterized by periods of remission and relapse, affecting people
at any age [1e3]. The aetiopathogenesis of IBD relies on complex
immune mechanisms, and is mediated by a genetic/epigenetic
predisposition and environmental factors [4e7]. Symptoms of IBD
include diarrhoea, abdominal pain, fatigue, appetite and weight
loss [8]. Moreover, IBD patients may often require both treatment
with immunodepressants [1,2,9e12], which may be associated
with signiﬁcant side-effects [13e15], and invasive/repeated surgi-
cal procedures for primary disease [1,2,16e19] as well as for po-
tential complications of the treatments [3,20e25]. Furthermore,
IBD patients and their relatives are at increased risk of immune-
driven cancerogenesis [26e28]. These observations justify the
consistent impact of IBD on health related quality of life [20,29].
Even if fatigue is known to be a common concern in chronic
diseases of the digestive system [30], there is lack of knowledge as.
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The condition is still unjustiﬁably overlooked in IBD patients, as
clinicians tend to concentrate on controlling problems related to
inﬂammation [31]. Our aim was to assess patient-reported fatigue
in IBD patients and in controls, seeking for potential inﬂuences of
age and disease activity.
2. Material and methods
All consecutive patients diagnosed with CD or UC aged between
16 and 75 years observed at our Unit from June 2011 through June
2012 were evaluated for inclusion.
Diagnosis of IBD was made following the accepted criteria
[32,33]. Patients willing to participate were included. IBD patients
with prior or current malignancies were excluded from the study.
Patients observed for perianal CD were excluded.
A control group of patients diagnosed with other-than-IBD
conditions was prospectively enrolled. Patients underwent sur-
gery for benign diseases, hence excluding cancer patients [34e38],
and were age- and sex-matched with IBD patients.
IBD patients and controls who were previously operated on for
any disease were not included.
Each group comprised half patients aged over 65 years to allow
sub-analyses.
2.1. Disease assessment
All patients underwent complete clinical examination. All IBD
patients underwent endoscopy with biopsies to conﬁrm the diag-
nosis [32,33]. Imaging modalities were selectively advocated
[17,32,33,35,37e40]. Disease activity assessment in CD and UC pa-
tients was performed by means of Crohn's disease activity index
(CDAI) [41] and Ulcerative Colitis Disease Activity Index (UCDAI)
[42], respectively.
2.2. Fatigue assessment
Fatigue was assessed by means of the fatigue impact scale (FIS)
questionnaire [43]. This is a self-reported instrument consisting of
40 questions, constructed to assess the impact of perceived fatigue
on the following dimensions: physical functioning (10 items),
cognitive functioning (10 items), and psychosocial functioning (20
items). Each question asks subjects to rate distress on a 5-point
scale, ranging from 0 (“no problem”) to 4 (“extreme problem”).
The maximum total FIS score is 160, corresponding to highest fa-
tigue perception.
2.3. Statistical analysis
Results of each group were compared, and sub-analyses were
performed according to age (< and >65 years). FIS scores of young
IBD patients were also compared with old IBD patients. Data areexpressed asmean ± standard deviations (SD). TheManneWhitney
test was performed for calculations of differences between groups.
Values of p < 0.05 were considered statistically signiﬁcant.
3. Results
Sixteen patients per group (10 female) were enrolled, of whom 8
(50%) were >65-year-old per group. Patients with IBD had more
severe overall fatigue compared with non-IBD controls (88 ± 70 vs
40 ± 25, p ¼ 0.002). Physical (IBD vs controls: all age, 25 ± 15 vs
12 ± 8, p ¼ 0.02) and psychosocial (36 ± 22 vs 21 ± 13, p ¼ 0.04) FIS
scores were higher in IBD compared with controls while no dif-
ferences were observed in cognitive FIS score (9 ± 7 vs 10 ± 8,
p ¼ 0.12). Results were conﬁrmed with subgroup analyses accord-
ing to age (< and >65 year-of-age).
When only considering IBD patients with moderate to severe
disease activity (n ¼ 5, 31.3%), differences in overall FIS scores were
even more apparent (IBD vs controls: all age, 100 ± 62 vs 40 ± 25,
p < 0.0001).
When only evaluating IBD patients with mild to low active
disease (n ¼ 11, 68.7%), young IBD patients showed a trend toward
higher FIS score compared with older IBD patients (73 ± 60 vs
65 ± 80, p ¼ 0.06), and signiﬁcantly higher fatigue than non-IBD
young counterparts (73 ± 60 vs 31 ± 42, p ¼ 0.001).
4. Discussion
With our exploratory, pilot study we were able to demonstrate
that IBD-associated fatigue affects the life of IBD patients, similarly
to other chronic diseases [30,43].
IBD activity signiﬁcantly impacted on perceived fatigue. Inter-
estingly, old IBD patients in remission seemed to cope better with
fatigue when compared with younger IBD patients. Patients aged
<65 years tended to experience more severe fatigue than non-IBD
controls.
Many factors may affect patient-perceived fatigue, and chronic
illnesses [30,43,44] and conditions are one of the most important.
However, also cancer patients may experience fatigue [45]. For this
reason, we decided to put out from analyses patients diagnosed
with malignancies [34e38,46e50] as this could have biased our
results.
Our ﬁndings offer interesting and practical perspectives. Many
factors may be responsible for higher fatigue perception in IBD,
including depression and anxiety [51]. This advocates the need of
further studies also evaluating these facets of IBD patients, which
are frequently overlooked.
Disease duration and activity have previously been associated
with higher fatigue levels [51]. Unsurprisingly, IBD patients with
more active disease were much more fatigued than both IBD pa-
tients with mild disease and non-IBD patients.
We found that age may play a role in fatigue perception, as
differences were observed in overall FIS score between young and
old IBD patients in remission. Even if without reaching statistical
signiﬁcance, these may suggest that patients with longer disease,
successfully controlled, may develop more effective coping strate-
gies than younger patients. As a matter of fact, young IBD in-
dividuals in remission had signiﬁcantly higher fatigue than same-
age controls. It can be hence predicted that timely, fatigue-
speciﬁc treatments may be needed in such patients, potentially
reducing the levels of perceived fatigue, on condition that the
baseline disease is controlled.
Further researches are compulsory to seek for potential associ-
ations between other factors which may play a role in perceived
levels of fatigue. These may ultimately result in the development of
accepted guidelines to strengthen and validate frameworks such as
G. Pellino et al. / International Journal of Surgery 12 (2014) S60eS63S62the “health-related normality” [52], including psychological,
behavioural, social, and medical strategies. Such approach could
lead to achieve the optimal management of IBD-related fatigue at
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